Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Asset Utilization Ratio (2016 - 2026)

Amphastar Pharmaceuticals has reported Asset Utilization Ratio over the past 12 years, most recently at 0.44 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 6.81% year-over-year to 0.44; the TTM value through Dec 2025 reached 0.44, down 6.81%, while the annual FY2025 figure was 0.45, 5.22% down from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.44 at Amphastar Pharmaceuticals, down from 0.44 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.68 in Q1 2023 and troughed at 0.41 in Q3 2023.
  • A 5-year average of 0.54 and a median of 0.49 in 2023 define the central range for Asset Utilization Ratio.
  • Biggest five-year swings in Asset Utilization Ratio: increased 17.73% in 2021 and later tumbled 38.46% in 2023.
  • Year by year, Asset Utilization Ratio stood at 0.66 in 2021, then rose by 2.69% to 0.68 in 2022, then crashed by 37.97% to 0.42 in 2023, then increased by 11.22% to 0.47 in 2024, then decreased by 6.81% to 0.44 in 2025.
  • Business Quant data shows Asset Utilization Ratio for AMPH at 0.44 in Q4 2025, 0.44 in Q3 2025, and 0.45 in Q2 2025.